129 related articles for article (PubMed ID: 17127070)
1. Synthesis and evaluation of unsaturated caprolactams as interleukin-1beta converting enzyme (ICE) inhibitors.
Wang Y; O'Neil SV; Wos JA; Oppong KA; Laufersweiler MC; Soper DL; Ellis CD; Baize MW; Fancher AN; Lu W; Suchanek MK; Wang RL; Schwecke WP; Cruze CA; Buchalova M; Belkin M; De B; Demuth TP
Bioorg Med Chem; 2007 Feb; 15(3):1311-22. PubMed ID: 17127070
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of thiazepines as interleukin-1beta converting enzyme (ICE) inhibitors.
Ellis CD; Oppong KA; Laufersweiler MC; O'Neil SV; Soper DL; Wang Y; Wos JA; Fancher AN; Lu W; Suchanek MK; Wang RL; De B; Demuth TP
Bioorg Med Chem Lett; 2006 Sep; 16(18):4728-32. PubMed ID: 16870441
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of tricyclic pyrrolopyrimidinones as dipeptide mimetics: inhibition of interleukin-1beta-converting enzyme.
Laufersweiler MC; Wang Y; Soper DL; Suchanek MK; Fancher AN; Lu W; Wang RL; Oppong KA; Ellis CD; Baize MW; O'Neil SV; Wos JA; Demuth TP
Bioorg Med Chem Lett; 2005 Oct; 15(19):4322-6. PubMed ID: 16046129
[TBL] [Abstract][Full Text] [Related]
4. Enantio- and diastereoselective total synthesis of EI-1941-1, -2, and -3, inhibitors of interleukin-1beta converting enzyme, and biological properties of their derivatives.
Shoji M; Uno T; Kakeya H; Onose R; Shiina I; Osada H; Hayashi Y
J Org Chem; 2005 Nov; 70(24):9905-15. PubMed ID: 16292821
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of novel 1-(2-acylhydrazinocarbonyl)-cycloalkyl carboxamides as interleukin-1beta converting enzyme (ICE) inhibitors.
Soper DL; Sheville J; O'Neil SV; Wang Y; Laufersweiler MC; Oppong KA; Wos JA; Ellis CD; Fancher AN; Lu W; Suchanek MK; Wang RL; De B; Demuth TP
Bioorg Med Chem Lett; 2006 Aug; 16(16):4233-6. PubMed ID: 16782334
[TBL] [Abstract][Full Text] [Related]
6. The design and synthesis of sulfonamides as caspase-1 inhibitors.
Harter WG; Albrect H; Brady K; Caprathe B; Dunbar J; Gilmore J; Hays S; Kostlan CR; Lunney B; Walker N
Bioorg Med Chem Lett; 2004 Feb; 14(3):809-12. PubMed ID: 14741295
[TBL] [Abstract][Full Text] [Related]
7. Total synthesis of the interleukin-1beta converting enzyme inhibitor EI-1941-2 using tandem oxa-electrocyclization/oxidation1.
Kleinke AS; Li C; Rabasso N; Porco JA
Org Lett; 2006 Jun; 8(13):2847-50. PubMed ID: 16774272
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of novel 8,5-fused bicyclic peptidomimetic compounds as interleukin-1beta converting enzyme (ICE) inhibitors.
Soper DL; Sheville JX; O'Neil SV; Wang Y; Laufersweiler MC; Oppong KA; Wos JA; Ellis CD; Baize MW; Chen JJ; Fancher AN; Lu W; Suchanek MK; Wang RL; Schwecke WP; Cruze CA; Buchalova M; Belkin M; Wireko F; Ritter A; De B; Wang D; Demuth TP
Bioorg Med Chem; 2006 Dec; 14(23):7880-92. PubMed ID: 16908171
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel conformationally restricted diazocan peptidomimetics as inhibitors of interleukin-1beta synthesis.
Oppong KA; Ellis CD; Laufersweiler MC; O'Neil SV; Wang Y; Soper DL; Baize MW; Wos JA; De B; Bosch GK; Fancher AN; Lu W; Suchanek MK; Wang RL; Demuth TP
Bioorg Med Chem Lett; 2005 Oct; 15(19):4291-4. PubMed ID: 16046125
[TBL] [Abstract][Full Text] [Related]
10. Succinic acid amides as P2-P3 replacements for inhibitors of interleukin-1beta converting enzyme (ICE or caspase 1).
Galatsis P; Caprathe B; Gilmore J; Thomas A; Linn K; Sheehan S; Harter W; Kostlan C; Lunney E; Stankovic C; Rubin J; Brady K; Allen H; Talanian R
Bioorg Med Chem Lett; 2010 Sep; 20(17):5184-90. PubMed ID: 20656488
[TBL] [Abstract][Full Text] [Related]
11. ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy.
Vezzani A; Balosso S; Maroso M; Zardoni D; Noé F; Ravizza T
Curr Opin Investig Drugs; 2010 Jan; 11(1):43-50. PubMed ID: 20047158
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel 8,6-fused bicyclic peptidomimetic compounds as interleukin-1beta converting enzyme inhibitors.
O'Neil SV; Wang Y; Laufersweiler MC; Oppong KA; Soper DL; Wos JA; Ellis CD; Baize MW; Bosch GK; Fancher AN; Lu W; Suchanek MK; Wang RL; De B; Demuth TP
Bioorg Med Chem Lett; 2005 Dec; 15(24):5434-8. PubMed ID: 16216507
[TBL] [Abstract][Full Text] [Related]
13. Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1).
Asano Y; Kitamura S; Ohra T; Aso K; Igata H; Tamura T; Kawamoto T; Tanaka T; Sogabe S; Matsumoto S; Yamaguchi M; Kimura H; Itoh F
Bioorg Med Chem; 2008 Apr; 16(8):4715-32. PubMed ID: 18313304
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyl-terminated peptidomimetic inhibitors of neuronal nitric oxide synthase.
Mbadugha BN; Seo J; Ji H; Martásek P; Roman LJ; Shea TM; Li H; Poulos TL; Silverman RB
Bioorg Med Chem; 2006 Jun; 14(11):3681-90. PubMed ID: 16480878
[TBL] [Abstract][Full Text] [Related]
15. Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (2).
Asano Y; Kitamura S; Ohra T; Itoh F; Kajino M; Tamura T; Kaneko M; Ikeda S; Igata H; Kawamoto T; Sogabe S; Matsumoto S; Tanaka T; Yamaguchi M; Kimura H; Fukumoto S
Bioorg Med Chem; 2008 Apr; 16(8):4699-714. PubMed ID: 18313930
[TBL] [Abstract][Full Text] [Related]
16. Pyridazinodiazepines as a high-affinity, P2-P3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitor.
Dolle RE; Prasad CV; Prouty CP; Salvino JM; Awad MM; Schmidt SJ; Hoyer D; Ross TM; Graybill TL; Speier GJ; Uhl J; Miller BE; Helaszek CT; Ator MA
J Med Chem; 1997 Jun; 40(13):1941-6. PubMed ID: 9207934
[No Abstract] [Full Text] [Related]
17. Modeling caspase-1 inhibition: Implications for catalytic mechanism and drug design.
Ramos-Guzmán CA; Zinovjev K; Tuñón I
Eur J Med Chem; 2019 May; 169():159-167. PubMed ID: 30875506
[TBL] [Abstract][Full Text] [Related]
18. The synthetic tellurium compound, AS101, is a novel inhibitor of IL-1beta converting enzyme.
Brodsky M; Yosef S; Galit R; Albeck M; Longo DL; Albeck A; Sredni B
J Interferon Cytokine Res; 2007 Jun; 27(6):453-62. PubMed ID: 17572009
[TBL] [Abstract][Full Text] [Related]
19. Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
Dang Q; Kasibhatla SR; Reddy KR; Jiang T; Reddy MR; Potter SC; Fujitaki JM; van Poelje PD; Huang J; Lipscomb WN; Erion MD
J Am Chem Soc; 2007 Dec; 129(50):15491-502. PubMed ID: 18041834
[TBL] [Abstract][Full Text] [Related]
20. Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?
Adkison KK; Barrett DG; Deaton DN; Gampe RT; Hassell AM; Long ST; McFadyen RB; Miller AB; Miller LR; Payne JA; Shewchuk LM; Wells-Knecht KJ; Willard DH; Wright LL
Bioorg Med Chem Lett; 2006 Feb; 16(4):978-83. PubMed ID: 16290936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
